News | May 02, 2007

Set to Launch at HRS, New Coalition Will Urge Federal Government to Get Serious on Sudden Cardiac Arrest

May 3, 2007 — Next Thursday, May 10, in Denver, CO, more than 25 leading heart advocacy groups will announce the formation of the Sudden Cardiac Arrest (SCA) Coalition, dedicated to advancing increased research, awareness and educational efforts to address the nation’s No. 1 cardiovascular killer.

The coalition will use its collective strength of physicians, patients, caregivers, first responders and other supporters to urge Congress and federal agencies involved in national health policies and programs to devote more resources to greater public awareness of SCA, research and access to life-saving therapies. The federal government has made great strides in research and treatment advances for many of our major health threats — breast cancer, lung cancer, AIDS and stroke. Members of the coalition believe the nation needs to now focus increased attention to a killer that takes more American lives every year than any of those diseases.

The announcement, which will take place as part of Heart Rhythm 2007, the Society’s 28th Annual Scientific Sessions, will also include the release of a national survey which will demonstrate that a critical mass of Americans are concerned about the threat of SCA to their families, the lack of awareness of warning signs, risk factors, and treatment options and the need for more research on sudden cardiac arrest.

Featured speakers at the press conference will include: Dr. Dwight Reynolds, president of the Heart Rhythm Society, one of the founders of the SCA Coalition; Diane Canova, executive director of the Sudden Cardiac Arrest Association, a patient advocacy group, and co-chair of the SCA Coalition; and Judy Sudmeier, a Denver nurse who survived SCA nearly three years ago.


Related Content

News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
Subscribe Now